Replies to post #117024 on Biotech Values

[AlpineBV_Miller]

Provenge will be the cheapest (or in the bottom couple) cancer biologics approved this decade.

(ok, for the AR folks out there, 2010 forward since technically the decade started 2011)

[DewDiligence]

Renzo Canetta used the C-word to describe Ipilimumab on a recent webcast. That should have been a tip-off about the sky-high price.